Table 2.
Characteristics (n) | Parameters |
---|---|
Number of [68Ga]Ga-PSMA-11 PET/CT patients | 136 |
Age (y) | |
- Median | 70 |
- Range | 49–94 |
- Mean ± SD | 69.2 ± 8.3 |
Gleason Score | |
- ≤6 (low risk + grade group 1) | 6 |
- 7 (intermediate risk + grade group 2 + 3) | 82 |
- 8 (high risk + grade group 4) | 27 |
- >8 (high risk + grade group 5) | 21 |
PSA (ng/mL) | |
- Median | 3.2 |
- Range | 0.1–170 |
- Mean ± SD | 10.4 ± 24.4 |
Pretreatment of primary tumor | |
- Surgery (radical prostatectomy) | 92 |
- Radiotherapy | 44 |
Further treatment | |
- Androgen deprivation therapy | 60 |
Positivity rate | |
- PET/CT positive patients/total | 121/136 |
Abbreviations: PSA, prostate-specific antigen; SD, standard deviation; n, number of patients; y, year.